What is Rh sensitization during pregnancy?If your blood is
Rh-negative and your unborn baby’s blood is
Rh-positive, your body’s natural defense system can make your unborn baby
(fetus) sick. This happens because your body makes a substance that can destroy
the baby’s red blood cells. This reaction is called Rh sensitization. Rh sensitization can only happen to women with Rh-negative blood.
You cannot become Rh-sensitized if your blood is Rh-positive. This condition does not happen often and can almost always be
prevented. It is one reason why you need to see your doctor regularly when you
are pregnant. What causes Rh sensitization during pregnancy?Rh sensitization happens when the mother’s Rh-negative blood
mixes with the baby’s Rh-positive blood. For most women, this happens during
childbirth. It may also happen during a miscarriage or abortion, or in women
who share needles to take illegal drugs. If you are pregnant and have Rh-negative blood, and the father
of the baby has Rh-positive blood, your fetus could have Rh-positive blood.
If both you and the baby’s father have Rh-negative blood, your
baby will be Rh-negative. In this case, there is no chance of Rh sensitization.
Does Rh sensitization in the mother harm the fetus?Rh sensitization usually does not hurt your unborn baby (fetus)
the first time you are pregnant. But in your next pregnancy, it can make your
fetus sick. The fetus can develop
anemia, also known as
hemolytic disease of the fetus and newborn. If
untreated, sensitization can cause severe swelling of the fetus's body (hydrops fetalis). In rare cases, the fetus may
die. What are the symptoms of Rh sensitization?You will not have any unusual symptoms when you are Rh sensitive,
so your doctor will closely watch your pregnancy. Regular blood tests can help
your doctor watch the health and growth of your fetus. As the pregnancy progresses, a fetus with severe Rh disease may
move less often than before. How is Rh sensitization diagnosed?A simple blood test can check for
Rh incompatibility. This is usually done at the first
visit early in your pregnancy, before the 12th week. If this test shows that your blood is Rh-negative, your doctor
will know to watch your pregnancy carefully. You will also have a blood test to
see if you are already Rh-sensitized. If the test shows that you are not Rh-sensitized, you may have
another test between your 24th and 28th weeks of pregnancy. If that test also
shows that you are not sensitized, you will not have more Rh tests until
delivery unless you get another problem, such as
placenta abruptio. If your newborn is Rh-positive, you will have more blood tests
to find out if you were sensitized in late pregnancy or childbirth. If your first blood test shows that you are Rh-sensitized (or if
you become sensitized during this pregnancy), your doctor will watch closely to
see if your fetus is being harmed. This will include regular blood tests and
other tests. How is Rh sensitization treated?A shot of medicine called
immune globulin can greatly lower your chances of Rh
sensitization. You must get the shot around week 28 of your pregnancy to
prevent sensitization late in your pregnancy or during delivery. If your baby
is Rh-positive at birth, you will have another shot of Rh immune globulin after
delivery. For pregnant women who are already Rh-sensitized from a past
pregnancy, Rh immune globulin cannot help. Instead, the goal of treatment is to
prevent or reduce harm to the fetus and prevent early (preterm) delivery.
Treatment choices depend on how badly your fetus may be harmed by the Rh
sensitization. Frequently Asked Questions |
Learning about Rh sensitization during
pregnancy: |
| |
Being diagnosed: |
| |
Getting treatment: |
| |
Ongoing concerns: |
| |
Living with Rh
sensitization: |
|
Rh sensitization can occur when a person with
Rh-negative blood is exposed to Rh-positive blood.
About 90% of women who become sensitized do so during childbirth, when their
blood mixes with the Rh-positive blood of their fetus.1 Once exposed, a mother's
immune system produces
antibodies against Rh-positive red blood cells. For
more information about events and procedures that can put you at high risk for
Rh sensitization, see the What Increases Your Risk section of this topic.
The minimum amount of blood mixing necessary to cause sensitization
is not known. However, many women become sensitized during pregnancy or
childbirth after being exposed to as little as
0.1 mL of Rh-positive fetal blood.1, 2 Fortunately, Rh sensitization
can almost always be prevented with the
Rh
immune globulin injection. When an Rh-negative person's immune system is first exposed to
Rh-positive blood, it takes several weeks to develop immunoglobulin M, or IgM,
antibodies. IgM antibodies are too large to cross the
placenta. Therefore, the Rh-positive fetus that first
triggers maternal sensitization is usually not harmed. A previously Rh-sensitized immune system rapidly reacts to
Rh-positive blood, as during a second pregnancy with an Rh-positive fetus.
Usually within hours of Rh-positive blood exposure, smaller immunoglobulin G,
or IgG, antibodies are formed. IgG antibodies can cross the placenta and
destroy fetal red blood cells. Some Rh-negative people never become sensitized, even after
exposure to large amounts of Rh-positive blood. The reason for this is not
known.
If you are already
Rh-sensitized or become Rh-sensitized while pregnant,
you will not have any unusual symptoms. Fetal problems from Rh sensitization are detected with diagnostic
testing. It is possible, however, that a fetus with severe Rh disease will move
less frequently than before. Other
conditions with symptoms similar to Rh sensitization
include other blood type incompatibility problems and fetal infections.
If you are Rh-negativeUnless you are given
Rh
immune globulin prior to or just after a high-risk event, such as
miscarriage,
amniocentesis, or childbirth, you have a chance of
becoming sensitized to an Rh-positive fetus's blood. If you have been Rh-sensitized in the pastIf you have been Rh-sensitized in the past, you must be closely
monitored during any pregnancy with an Rh-positive partner, because
your
fetus is more likely to have Rh-positive blood. In response to an
Rh-positive fetus, your immune system may quickly develop IgG antibodies, which
can cross the placenta and destroy fetal red blood cells. Each subsequent
pregnancy with an Rh-positive fetus may produce more serious problems for the
fetus. The resulting fetal disease (called Rh disease,
hemolytic disease of the newborn, or erythroblastosis
fetalis) can be mild to severe. - Mild Rh disease involves limited destruction
of fetal red blood cells, possibly resulting in mild fetal
anemia. The fetus can usually be carried to term and
requires no special treatment but may have problems with
jaundice after birth. Mild Rh disease is more likely
to develop in the first pregnancy after sensitization has
occurred.
- Moderate Rh disease involves the destruction of larger
numbers of fetal red blood cells. The fetus may develop an enlarged
liver and may become moderately anemic. The fetus may
need to be delivered before term and may require a blood transfusion before or
after birth. A newborn with moderate Rh disease is watched closely for
jaundice.
- Severe Rh disease (fetal hydrops)
involves widespread destruction of fetal red blood cells. The fetus develops
severe
anemia, liver and
spleen enlargement, increased
bilirubin levels, and fluid retention (edema). One or
more blood transfusions may be necessary before birth. A fetus with severe Rh
disease who survives the pregnancy may need a blood exchange. This procedure
replaces most of the infant's blood with donor blood (usually type O,
Rh-negative).
- A history of pregnancy with severe Rh disease is a
sign that you will need special treatment when you are pregnant with an
Rh-positive fetus.
If you have been Rh-sensitized in the past, an Rh-negative fetus
cannot trigger an immune reaction.
Rh sensitization can occur when a person with
Rh-negative blood is exposed to Rh-positive blood.
During pregnancy, an Rh-negative woman can become
sensitized if she is carrying an Rh-positive
fetus. Factors that increase the risk of blood mixing and sensitization
during pregnancy include:3 Although rare, Rh sensitization has been known to occur after
needle sharing between intravenous drug users. Transfusing Rh-positive blood in
an Rh-negative person can also trigger sensitization; however, this is
extremely rare because blood is always tested prior to transfusion.
If you are already Rh-sensitized and are pregnantYour pregnancy will be closely monitored. Discuss possible
symptoms early in pregnancy with your health professional. Repeated diagnostic
testing will be necessary to monitor the fetus. Call your health professional immediately
if you note a decrease in your fetus's movement after 24 to 26 weeks of
pregnancy. If you are Rh-negativeCall your health professional immediately
if you: - Think you may have been pregnant and
miscarried.
- Are pregnant and have had an accident that may have
injured your abdomen.
Regular prenatal visits are essential. Repeated diagnostic testing
will be necessary to monitor for Rh
antibodies in your blood. Watchful WaitingWatchful waiting is not appropriate when Rh sensitization has
occurred. It is important to keep all prenatal appointments so that your
developing fetus can be closely monitored throughout your pregnancy. Who To See A woman who may have problems with
Rh incompatibility or
sensitization can be treated by: If you test positive for Rh-sensitization, your health care
system or health professional may want you to be followed and treated by a
perinatologist or an obstetrician who can easily call in a
perinatologist. To prepare for your appointment, see the topic
Making the Most of Your Appointment.
Initial tests for determining
Rh incompatibility are done by testing your blood,
usually at the first prenatal visit in the first
trimester. If you are Rh-negative and your partner is
Rh-positive,
your
fetus is likely to be Rh-positive. The following tests are also used when a woman has
miscarried or has had a medical abortion, a
partial molar pregnancy, or an
ectopic pregnancy. If you are Rh-negativeAll pregnant women have an
indirect Coombs' test during early pregnancy. - At the first prenatal visit, your blood is
tested to determine whether you have been previously sensitized to Rh-positive
blood. If you are Rh-negative and test results show that you are not
sensitized, a repeat test may be done between 24 and 28 weeks.
- If
test results at 28 weeks show that sensitization has not occurred, no
additional tests for Rh-related problems are done until delivery (barring
complications such as
placenta abruptio).
- If your newborn is
found to be Rh-positive, your blood will be screened again at delivery with an
indirect Coombs' test to determine whether you have been sensitized during late
pregnancy or childbirth.
If you are sensitized to the Rh factorIf you are already
Rh-sensitized or become sensitized while pregnant,
close monitoring is important to determine whether your fetus is being harmed.
- An
indirect Coombs' test is done periodically during your
pregnancy to determine whether your Rh-positive antibody levels are increasing.
This is the typical course of treatment for the majority of sensitized women
during pregnancy.
- Fetal
Doppler ultrasound of blood flow in the brain shows fetal anemia and how bad it is. This test can give you the same information as amniocentesis, without the risks.4
- Amniocentesis may be done:
- At or after 15 weeks to examine
amniotic fluid for substances that indicate fetal
problems.
- To learn the fetal
blood type and Rh factor.
- On a repeated
basis to check fetal anemia. This tells how much a fetus is being affected by sensitization.
- Fetal blood sampling (cordocentesis) may be done to
directly assess your fetus's health. This procedure is used on a limited basis,
usually for monitoring known sensitization problems (as when a mother has had
previous fetal deaths, or other testing has indicated fetal
distress).
- Electronic fetal heart monitoring
(nonstress test) may be done in the third trimester to check your fetus's
condition. Unusual fetal heart rhythms detected during a nonstress test may be
a sign that the fetus has
anemia related to the sensitization.
- Fetal ultrasound testing can be used as a pregnancy
progresses to detect sensitization problems, such as fetal fluid retention (a
sign of severe Rh disease).
Early DetectionEarly prenatal Rh blood typing and testing for Rh sensitization
is necessary to ensure that every vulnerable fetus can be properly monitored
and treated.
If you are Rh-negativeIf you are unsensitized
Rh-negative and your partner is Rh-positive, treatment
focuses on preventing
Rh sensitization during pregnancy and childbirth.
Rh
immune globulin (such as RhoGAM) is a highly effective treatment for
preventing sensitization. - To prevent sensitization from occurring late
in the pregnancy or during delivery, you must be injected with Rh immune
globulin around week 28 of your pregnancy. This treatment prevents your immune
system from producing
antibodies against your fetus's Rh-positive red blood
cells.
- Rh immune globulin injection is also necessary if you have
had any vaginal bleeding or an obstetric procedure such as
amniocentesis or
external cephalic version.
- If your newborn
is Rh-positive, you are given Rh immune globulin again within 72 hours of
delivery. By preventing Rh sensitization from delivery, you are protecting your
next Rh-positive fetus.
- If your newborn is Rh-negative, sensitization cannot happen,
and no treatment is necessary.
Rh immune globulin is also necessary after a
miscarriage,
partial molar pregnancy,
ectopic pregnancy, or abortion. If you are sensitized to the Rh factorIf you are already Rh-sensitized, your treatment will focus on
preventing or minimizing fetal harm and on avoiding early (preterm) delivery.
Treatment options depend on the severity of fetal harm. - If testing shows that your fetus is only
mildly affected by your Rh factor antibodies, you will be closely monitored
until your pregnancy reaches term. Your fetus will be delivered early only if
his or her condition worsens.
- If testing shows that your fetus is
moderately affected by your Rh antibodies, your fetus's condition will be
closely monitored until his or her lungs are mature enough for a preterm
delivery. A
cesarean section may be used to deliver the baby
quickly or to avoid the difficulty of
inducing labor before term. A moderately affected
newborn sometimes requires a blood transfusion immediately after
birth.
- If testing shows that your fetus is severely affected by
your Rh factor antibodies, a blood transfusion may be given before birth (intrauterine fetal blood transfusion). This can be
done through the fetus's abdomen or directly into the fetus's umbilical cord. A
preterm delivery is likely. Multiple blood transfusions are sometimes necessary
to keep a fetus healthy until the fetal lungs mature enough to function after
birth. Frequently, a
cesarean section is done to deliver the baby quickly.
A blood transfusion is sometimes necessary immediately
after birth.
If you are an
Rh-negative woman and you have conceived with an
Rh-negative partner, you are not at risk of Rh sensitization during pregnancy.
If you are Rh-negative and your partner is Rh-positive, Rh
sensitization is almost entirely preventable with
Rh
immune globulin injection. This will protect future pregnancies from Rh
problems. If you are already sensitized to the Rh factor, your pregnancy will
need to be closely monitored to prevent fetal harm. For more information on
fetal and newborn treatment, see the Treatment Overview section of this
topic.
There is no home treatment for Rh sensitization. However, you can
take measures that ensure the healthiest pregnancy possible.
Use of
Rh
immune globulin is 99.8% effective in preventing
Rh sensitization.1 Rh
immune globulin contains Rh
antibodies that have been purified from human donors.
This treatment prevents an unsensitized Rh-negative mother from making
antibodies against her fetus's Rh-positive blood. If an affected fetus younger than 34 weeks needs to be delivered,
corticosteroid medication (betamethasone or
dexamethasone) may be given to the mother to speed fetal lung
development before a premature birth.
There is no surgical treatment for Rh sensitization during
pregnancy.
An
intrauterine fetal blood transfusion is sometimes used
to supply healthy blood to a fetus with severe
hemolytic disease of the newborn (also called Rh
disease or erythroblastosis fetalis). A
newborn blood transfusion or exchange transfusion is
sometimes given to treat severe
anemia or
jaundice related to Rh disease.
Organization| American College of Obstetricians and Gynecologists
(ACOG) | | 409 12th Street, S.W., P.O. Box 96920 | | Washington, DC 20090-6920 | | Phone: | 1-800-673-8444 (202) 638-5577 | | E-mail: | resources@acog.org | | Web Address: | http://www.acog.org | | | American College of Obstetricians and Gynecologists (ACOG) is a
nonprofit organization of professionals who provide health care for women. The
ACOG Resource Center publishes manuals and patient education materials. The Web
site has information on many women's health topics, including quitting
smoking. |
|
CitationsAmerican College of Obstetricians and Gynecologists
(1999). Prevention of Rh D alloimmunization. ACOG Practice Bulletin No. 4.
Obstetrics and Gynecology, 93(5):
1–7. Hartwell EA (1998). Use of Rh immune globulin: ASCP
practice parameter. American Journal of Clinical
Pathology, 110(3): 281–292. Porter TF, et al. (2003). Immunologic disorders in
pregnancy. In JR Scott et al., eds., Danforth's Obstetrics and
Gynecology, 9th ed., pp. 313–338. Philadelphia: Lippincott Williams and
Wilkins. American College of Obstetricians and Gynecologists (2006). Management of Alloimunization During Pregnancy. ACOG Practice Bulletin No. 75. Obstetrics and Gynecology, 108(20): 457–464.
Other Works ConsultedJackson M, Branch DW (2002). Alloimmunization in
pregnancy. In SG Gabbe et al., eds., Obstetrics: Normal and
Problem Pregnancies, 4th ed., pp. 893–929. New York: Churchill
Livingstone. Moise KJ Jr (2003). Management of rhesus
alloimmunization in pregnancy. Obstetrics and
Gynecology, 100(3): 600–611.
| Author | Kathe Gallagher, MSW | | Editor | Kathleen M. Ariss, MS | | Associate Editor | Lisa Shaw | | Primary Medical Reviewer | Patrice Burgess, MD - Family Medicine | | Specialist Medical Reviewer | Gregory A L Davies, MD, FRCSC, FACOG - Maternal-Fetal Medicine | | Specialist Medical Reviewer | Kirtly Jones, MD - Obstetrics and Gynecology | | Last Updated | November 10, 2005 |
|